Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 3
1981 2
1982 1
1984 2
1985 5
1986 2
1987 1
1988 1
1989 1
1990 1
1991 2
1992 2
1993 1
1994 2
1995 3
1996 1
1997 2
1998 2
1999 5
2000 2
2001 6
2002 1
2003 5
2004 8
2005 13
2006 11
2007 7
2008 8
2009 5
2010 4
2011 8
2012 6
2013 7
2014 1
2015 4
2016 5
2017 4
2018 6
2019 7
2020 5
2021 4
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

154 results
Results by year
Filters applied: . Clear all
Page 1
2-Weekly versus 3-weekly docetaxel to treat castration-resistant advanced prostate cancer: a randomised, phase 3 trial.
Kellokumpu-Lehtinen PL, Harmenberg U, Joensuu T, McDermott R, Hervonen P, Ginman C, Luukkaa M, Nyandoto P, Hemminki A, Nilsson S, McCaffrey J, Asola R, Turpeenniemi-Hujanen T, Laestadius F, Tasmuth T, Sandberg K, Keane M, Lehtinen I, Luukkaala T, Joensuu H; PROSTY study group. Kellokumpu-Lehtinen PL, et al. Among authors: turpeenniemi hujanen t. Lancet Oncol. 2013 Feb;14(2):117-24. doi: 10.1016/S1470-2045(12)70537-5. Epub 2013 Jan 4. Lancet Oncol. 2013. PMID: 23294853 Clinical Trial.
R-Bendamustine in the treatment of nodular lymphocyte-predominant Hodgkin lymphoma.
Prusila REI, Haapasaari KM, Marin K, Pollari M, Soini Y, Vornanen M, Karjalainen-Lindsberg ML, Turpeenniemi-Hujanen T, Kuittinen O. Prusila REI, et al. Among authors: turpeenniemi hujanen t. Acta Oncol. 2018 Sep;57(9):1265-1267. doi: 10.1080/0284186X.2018.1450522. Epub 2018 Mar 14. Acta Oncol. 2018. PMID: 29537344 No abstract available.
Incidence of solid cancer in patients with follicular lymphoma.
Sorigue M, Prusila REI, Jauhiainen J, Mercadal S, Postila A, Salmi P, Tanhua T, Tikkanen S, Kakko S, Kuitunen H, Pollari M, Nystrand I, Kuusisto MEL, Vasala K, Jantunen E, Korkeila E, Karihtala P, Sancho JM, Turpeenniemi-Hujanen T, Kuittinen O. Sorigue M, et al. Among authors: turpeenniemi hujanen t. Acta Oncol. 2019 Nov;58(11):1564-1569. doi: 10.1080/0284186X.2019.1643918. Epub 2019 Aug 1. Acta Oncol. 2019. PMID: 31368395
Real-time monitoring of human blood-brain barrier disruption.
Kiviniemi V, Korhonen V, Kortelainen J, Rytky S, Keinänen T, Tuovinen T, Isokangas M, Sonkajärvi E, Siniluoto T, Nikkinen J, Alahuhta S, Tervonen O, Turpeenniemi-Hujanen T, Myllylä T, Kuittinen O, Voipio J. Kiviniemi V, et al. Among authors: turpeenniemi hujanen t. PLoS One. 2017 Mar 20;12(3):e0174072. doi: 10.1371/journal.pone.0174072. eCollection 2017. PLoS One. 2017. PMID: 28319185 Free PMC article.
Twist and Zeb1 expression identify mycosis fungoides patients with low risk of disease progression.
Häyrinen MJ, Uotila PM, Sahi H, Haapasaari KM, Teppo HR, Soini Y, Lapela M, Vasala K, Turpeenniemi-Hujanen T, Ranki A, Kuusisto MEL, Kuittinen O. Häyrinen MJ, et al. Among authors: turpeenniemi hujanen t. J Eur Acad Dermatol Venereol. 2020 Feb;34(2):e95-e98. doi: 10.1111/jdv.16009. Epub 2019 Nov 12. J Eur Acad Dermatol Venereol. 2020. PMID: 31596985 No abstract available.
154 results